Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (71-80 of 192) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|October 4, 2005
Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2Marika T Granfors, Janne T Backman, Jouko Laitila, et al.
Annals of Emergency Medicine|January 27, 2005
Out-of-hospital administration of activated charcoal by emergency medical servicesAri O Alaspää, Markku J Kuisma, Kalle Hoppu, et al.
European Journal of Clinical Pharmacology|February 1, 2006
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinideLauri I Kajosaari, Tiina Jaakkola, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|March 1, 2002
Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomesXia Wen, Jun-Sheng Wang, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinideLauri I Kajosaari, Mikko Niemi, Janne T Backman, et al.
British Journal of Clinical Pharmacology|March 5, 2004
Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitroMarika T Granfors, Janne T Backman, Jouko Laitila, et al.
Pharmacogenomics|October 22, 2009
Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatinJenni E Keskitalo, Marja K Pasanen, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|September 9, 2008
Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxibVille V Hynninen, Klaus T Olkkola, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|June 10, 2011
No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acidXiaoqiang Xiang, Juha Vakkilainen, Janne T Backman, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazoleKari Raaska, Mikko Niemi, Mikko Neuvonen, et al.
Pageof 20

Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|October 4, 2005
Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2Marika T Granfors, Janne T Backman, Jouko Laitila, et al.
Annals of Emergency Medicine|January 27, 2005
Out-of-hospital administration of activated charcoal by emergency medical servicesAri O Alaspää, Markku J Kuisma, Kalle Hoppu, et al.
European Journal of Clinical Pharmacology|February 1, 2006
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinideLauri I Kajosaari, Tiina Jaakkola, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|March 1, 2002
Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomesXia Wen, Jun-Sheng Wang, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinideLauri I Kajosaari, Mikko Niemi, Janne T Backman, et al.
British Journal of Clinical Pharmacology|March 5, 2004
Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitroMarika T Granfors, Janne T Backman, Jouko Laitila, et al.
Pharmacogenomics|October 22, 2009
Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatinJenni E Keskitalo, Marja K Pasanen, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|September 9, 2008
Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxibVille V Hynninen, Klaus T Olkkola, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|June 10, 2011
No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acidXiaoqiang Xiang, Juha Vakkilainen, Janne T Backman, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazoleKari Raaska, Mikko Niemi, Mikko Neuvonen, et al.
Pageof 20